Literature DB >> 529021

Potential pitfalls in the conventional pharmacokinetic studies: effects of the initial mixing of drug in blood and the pulmonary first-pass elimination.

W L Chiou.   

Abstract

The classical concept of assuming that an i.v. dose instantaneously distributes into the central or plasma compartment is reviewed, as is the potential for pulmonary first-pass effect. Based on available literature, the concept is shown to lead to serious errors in estimating pharmacokinetic parameters, particularly for drugs with high clearance.

Mesh:

Substances:

Year:  1979        PMID: 529021     DOI: 10.1007/BF01062393

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  36 in total

1.  Estimation of hepatic first-pass effect of acetaminophen in humans after oral administration.

Authors:  W L Chiou
Journal:  J Pharm Sci       Date:  1975-10       Impact factor: 3.534

2.  Fate of prostaglandins E(1) and A(1) in the human pulmonary circulation.

Authors:  G L Hammond; L H Cronau; D Whittaker; C N Gillis
Journal:  Surgery       Date:  1977-06       Impact factor: 3.982

3.  Uptake of acetazolamide by human erythrocytes in vitro.

Authors:  S M Wallace; S Reigelman
Journal:  J Pharm Sci       Date:  1977-05       Impact factor: 3.534

4.  Method for the rapid estimation of the total body drug clearance and adjustment of dosage regimens in patients during a constant-rate intravenous infusion.

Authors:  W L Chiou; M A Gadalla; G W Peng
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

5.  Lidocaine disposition kinetics in monkey and man. I. Prediction by a perfusion model.

Authors:  N Benowitz; F P Forsyth; K L Melmon; M Rowland
Journal:  Clin Pharmacol Ther       Date:  1974-07       Impact factor: 6.875

6.  Midpoint back-extrapolation method for the rapid estimation of drugs' volume of distribution and dosage adjustment exhibiting multicompartmental characteristics.

Authors:  W L Chiou; S M Huang; Y C Huang
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1980-01

7.  Constant blood withdrawal method for area under plasma concentration-time curve.

Authors:  C R Kowarski; A A Kowarski
Journal:  J Pharm Sci       Date:  1978-06       Impact factor: 3.534

8.  Time-dependent change in renal clearance of bethanidine in humans.

Authors:  A N Chremos; D Shen; M Gibaldi; J D Proctor; J H Newman
Journal:  J Pharm Sci       Date:  1976-01       Impact factor: 3.534

9.  Degradation of porstaglandin F2alpha in the human pulmonary circulation.

Authors:  P Jose; U Niederhauser; P J Piper; C Robinson; A P Smith
Journal:  Thorax       Date:  1976-12       Impact factor: 9.139

10.  Prostaglandins: their disappearance from and release into the circulation.

Authors:  S H Ferreira; J R Vane
Journal:  Nature       Date:  1967-12-02       Impact factor: 49.962

View more
  16 in total

1.  Do plasma concentrations obtained from early arterial blood sampling improve pharmacokinetic/pharmacodynamic modeling?

Authors:  T M Beaufort; J H Proost; K Kuizenga; M C Houwertjes; U W Kleef; J M Wierda
Journal:  J Pharmacokinet Biopharm       Date:  1999-04

2.  A whole-body physiologically based pharmacokinetic model incorporating dispersion concepts: short and long time characteristics.

Authors:  R E Oliver; A F Jones; M Rowland
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-02       Impact factor: 2.745

3.  A compartmental analysis of the pharmacokinetics of propofol in sheep.

Authors:  G L Ludbrook; R N Upton; C Grant; A Martinez
Journal:  J Pharmacokinet Biopharm       Date:  1999-06

4.  Relationship of apparent systemic clearance to individual organ clearances: effect of pulmonary clearance and site of drug administration and measurement.

Authors:  R Mehvar
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

Review 5.  The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II).

Authors:  W L Chiou
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

6.  Induction speed is not a determinant of propofol pharmacodynamics.

Authors:  Anthony G Doufas; Maryam Bakhshandeh; Andrew R Bjorksten; Steven L Shafer; Daniel I Sessler
Journal:  Anesthesiology       Date:  2004-11       Impact factor: 7.892

Review 7.  [Target-controlled infusion. Clinical relevance and special features when using pharmacokinetic models].

Authors:  H Ihmsen; S Schraag; S Kreuer; J Bruhn; S Albrecht
Journal:  Anaesthesist       Date:  2009-07       Impact factor: 1.041

8.  Determination of the distribution volume that can be used to calculate the intravenous loading dose.

Authors:  D R Wada; D R Drover; H J Lemmens
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

9.  A recirculatory model of the pulmonary uptake and pharmacokinetics of lidocaine based on analysis of arterial and mixed venous data from dogs.

Authors:  T C Krejcie; M J Avram; W B Gentry; C U Niemann; M P Janowski; T K Henthorn
Journal:  J Pharmacokinet Biopharm       Date:  1997-04

10.  A comparison of the pharmacokinetics of meropenem after intravenous administration by injection over 2, 3 and 5 minutes.

Authors:  H K Jones; H C Kelly; M Hutchison; R A Yates; F Ross; C Lomax; S Freestone; D Webb
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Jul-Sep       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.